Read + Share
Amedeo Smart
Independent Medical Education
Taniguchi N, Sakai M, Masuda T, Otsuki C, et al. Urinary beta2-microglobulin as a Potential Biomarker for Early Treatment Selection: A Patient with Severe IgG4-related Tubulointerstitial Nephritis. Intern Med 2026;65:457-463.PMID: 40670096
Email
LinkedIn
Privacy Policy